NOLVX
Price
$23.84
Change
+$0.20 (+0.85%)
Updated
Dec 3 closing price
Net Assets
68.01M
VIVAX
Price
$74.34
Change
+$0.66 (+0.90%)
Updated
Dec 3 closing price
Net Assets
207.95B
Interact to see
Advertisement

NOLVX vs VIVAX

Header iconNOLVX vs VIVAX Comparison
Open Charts NOLVX vs VIVAXBanner chart's image
Northern Large Cap Value
Price$23.84
Change+$0.20 (+0.85%)
VolumeN/A
Net Assets68.01M
Vanguard Value Index I
Price$74.34
Change+$0.66 (+0.90%)
VolumeN/A
Net Assets207.95B
NOLVX vs VIVAX Comparison Chart in %
View a ticker or compare two or three
VS
NOLVX vs. VIVAX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NOLVX is a Buy and VIVAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 208B vs. NOLVX (68M). VIVAX pays higher dividends than NOLVX: VIVAX (1.93) vs NOLVX (1.55). NOLVX was incepted earlier than VIVAX: NOLVX (25 years) vs VIVAX (33 years). NOLVX (0.77) is less costly to investors than VIVAX (0.17). NOLVX is a more actively managed with annual turnover of: 60.87 vs. VIVAX (9.00). NOLVX has a lower initial minimum investment than VIVAX: NOLVX (2500) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 4.76 vs. NOLVX (3.21). VIVAX return over 5 years is better than : 61.14 vs. NOLVX (45.28).
NOLVXVIVAXNOLVX / VIVAX
Total Expense Ratio0.570.17335%
Annual Report Gross Expense Ratio0.770.17453%
Fund Existence25 years33 years-
Gain YTD16.19211.753138%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets68M208B0%
Annual Yield % from dividends1.551.9381%
Returns for 1 year3.214.7667%
Returns for 3 years20.6729.7969%
Returns for 5 years45.2861.1474%
Returns for 10 years108.05127.2185%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORBN24.63N/A
N/A
Oregon Bancorp, Inc.
SRTOY23.71N/A
N/A
Sartorius Stedim Biotech
APTOF1.65N/A
N/A
Aptose Biosciences. Inc.
SMSZF8.56N/A
N/A
SMS Co., Ltd.
WPPGF4.19N/A
N/A
WPP PLC